Learn more

BASF BEAUTY CARE SOLUTIONS F

Overview
  • Total Patents
    113
  • GoodIP Patent Rank
    69,868
About

BASF BEAUTY CARE SOLUTIONS F has a total of 113 patent applications. Its first patent ever was published in 2003. It filed its patents most often in Republic of Korea, WIPO (World Intellectual Property Organization) and Japan. Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and measurement are ADVANGEN INC, ITALMED S N C DI GALLI G E PAC and MALLARD CLAIRE.

Patent filings per year

Chart showing BASF BEAUTY CARE SOLUTIONS Fs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Perrier Eric 58
#2 Andre Valerie 41
#3 Bechetoille Nicolas 23
#4 Reymermier Corinne 23
#5 Orly Isabelle 22
#6 Bonnet Isabelle 17
#7 Pain Sabine 16
#8 Altobelli Cecile 15
#9 Rival Delphine 13
#10 Dezutter Colette 11

Latest patents

Publication Filing date Title
WO2016055737A1 Deglycation activity of a combination of an extract of salvia miltiorrhiza and of niacin and/or niacinamide
JP2015147798A Stimulation of synthesis and of activity of isoform of loxl (lysyl oxidase-like) for stimulating formation of elastic fiber
KR20150029669A Use of substances to protect fgf-2 or fgf-beta growth factor
WO2015067525A1 Oligopeptides and uses of same
EP3043873A1 Cosmetic or dermatological use of an extract of tapirira guianensis
CN104736136A Cosmetic or pharmaceutical moisturising ingredient
FR3003758A1 COSMETIC OR DERMATOLOGICAL USE OF A POLYGONUM BISTORTA EXTRACT
FR3000488A1 NOVEL DERIVATIVES OF SINAPIC ACID AND THEIR COSMETIC OR PHARMACEUTICAL USES
FR2999926A1 USES OF A DNA METHYLATION INHIBITORY SUBSTANCE FOR STIMULATING THE FORMATION OF ELASTIC FIBERS
FR2997406A1 HYALURONATE AND GLUCOMANNAN POLYMER
FR2976587A1 In vitro dosing method by immunological technique
FR2954702A1 Agent stimulating the expression of loxl
JP2010059196A Synthesis of loxl (lysyl oxidase-like) isoform for stimulating formation of elastic fiber, and stimulation of activity
KR20160028495A Slimming composition
KR20100040737A Slimming composition
FR2928548A1 SUBSTANCES INCREASING THRESHOLD OF ACTIVATION OF IMMUNE CELLS
FR2927632A1 Cornea and muqueuse reconstructed.